Doug Hampton HELSINKI, May 16, 2023 /PRNewswire/ — Askel Healthcare, the Finnish medical technology company offering a new method for the treatment of knee cartilage damage, has started a fundraising campaign to raise up to 5 million euros to finance clinical trials of its COPLA® implant. The public phase of the ongoing fundraising campaign started today and closes on … Read more
VADUZ, Liechtenstein, May 16, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med. Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site’s RefluxStop™ results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world’s premier meeting for gastrointestinal professionals Dr. med. … Read more
Worn by Audrey Fleurot, the HPI series follows the adventures of Morgane Alvaro – a character with high intellectual potential – recruited by the police for her intellectual abilities beyond normal. Season 3, which begins on TF1, is an opportunity to focus on the realities and myths inherent in this intellectual trait. Dropping out of … Read more
the essential Six residents of a nursing home in Troyes, aged 84 to 99, climbed the 327 steps to the first floor of the Eiffel Tower in Paris on Monday May 15. Accompanied by a sports coach, they had been training for several months. It’s a challenge they rose to with flying colors. Six residents … Read more
– Conduct collaborative research on Sony’s unique polymeric materials to achieve high-DAR ADC – TOKYO, May 16, 2023 /PRNewswire/ — Sony Corporation (President and CEO: Kimio Maki, “Sony”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that they have entered into a collaborative research agreement to discover a novel Antibody-Drug Conjugate (ADC)*1 … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — Strong eGFR Data from Positive NefIgArd Phase 3 Trial Readout “In March we announced that the global NefIgArd Phase 3 trial successfully met its primary endpoint, estimated glomerular filtration rate (eGFR), with a p value < 0.0001. Achieving this clinically relevant endpoint of kidney filtration capability represents a crowning … Read more
STOCKHOLM, May 16, 2023 /PRNewswire/ — Strong eGFR Data from Positive NefIgArd Phase 3 Trial Readout “In March we announced that the global NefIgArd Phase 3 trial successfully met its primary endpoint, estimated glomerular filtration rate (eGFR), with a p value < 0.0001. Achieving this clinically relevant endpoint of kidney filtration capability represents a crowning … Read more
Accelerating Research and Development, and Access and Delivery for NTDs TOKYO, May 16, 2023 /PRNewswire/ — On May 12th, the eve of the G7 Health Ministers’ Meeting, global health leaders from around the world convened in Nagasaki to call for the prioritization of neglected tropical diseases (NTDs). Gathering at the Symposium for G7 Health Ministers’ … Read more
the essential A pharmacy in the center provides a teleconsultation terminal. An alternative solution in case of difficulties to make an appointment quickly. The Villefranchois know it, it is not always easy to make an emergency appointment with your doctor. According to a study on health in rural areas, presented at the Congress of Rural … Read more
the essential At the end of a public meeting, about fifty representatives of the Aude Federation of the Communist Party went in procession in front of the buildings of the ARS and the prefecture, in Carcassonne, to read there the “declaration of state emergency” forwarded to these two institutions. Meeting requests are also made. If … Read more